ISIN | LU1645385912 |
---|---|
Valor Number | 37504772 |
Bloomberg Global ID | |
Fund Name | UBS (Lux) Fund Solutions - J.P. Morgan USD EM Diversified Bond 1-5 UCITS ETF (USD) A-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Bond Emerging Global |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index (Total Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below. |
Peculiarities |
Current Price * | 15.16 USD | 03.04.2025 |
---|---|---|
Previous Price * | 15.19 USD | 02.04.2025 |
52 Week High * | 15.20 USD | 20.03.2025 |
52 Week Low * | 15.16 USD | 03.04.2025 |
NAV * | 15.16 USD | 03.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 396,742,067 | |
Unit/Share Assets *** | 718,699 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
YTD Performance (in CHF) | - | - |
1 month | -0.01% |
17.03.2025 - 03.04.2025
17.03.2025 03.04.2025 |
3 months | - | - |
6 months | - | - |
1 year | - | - |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Kuwait (State Of) | 1.15% | |
---|---|---|
Poland (Republic of) | 0.73% | |
Ghana (Republic of) | 0.71% | |
Oman (Sultanate Of) | 0.69% | |
Teva Pharmaceutical Finance Netherlands III B.V. | 0.67% | |
PETRONAS Capital Ltd. | 0.64% | |
Romania (Republic Of) | 0.64% | |
Philippines (Republic Of) | 0.59% | |
Dominican Republic | 0.58% | |
Standard Chartered PLC | 0.58% | |
Last data update | 01.04.2025 |
TER | 0.35% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.35% |
Ongoing Charges *** | 0.34% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |